3D Culture in Functionalized FN-Silk Networks Facilitate Proliferation, Differentiation and Phenotypic Stability of Mature Human Primary Cells and Stem Cells.
Källén A., Taebnia N., Widhe M., Lauschke VM., Hedhammar M.
Laboratory Study, published in Biotechnol Bioeng (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Biotechnol Bioeng (2025)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 40525899
- DOI
- 10.1002/bit.70002
Abstract (original English)
The recombinant functionalized silk protein FN-silk, including a cell adhesion motif from fibronectin, can form networks suitable for 3D culture of adherent cells. Such FN-silk networks have previously been shown to support the growth and differentiation of a wide array of cell types. Herein, we have developed a user-friendly methodology for the creation of free-floating FN-silk networks in 96-well plates with both mature human primary cells and stem cells. We show that human mesenchymal stem cells (hMSC) cultured in FN-silk networks form both cell-cell and cell-matrix contacts, resulting in tissue-mimicking 3D cultures. Viability and expression analysis revealed that hMSC in FN-silk networks have an initial proliferative phase with high cell viability and significantly lower hypoxia and apoptosis, compared to when cultured as scaffold-free spheroids. The FN-silk networks were shown to support differentiation of hMSC into adipocyte-like cells with well-maintained viability during the 3-week-long differentiation period, in contrast to the very poor long-term viability of scaffold-free 3D cultures. Improved adipogenesis was confirmed by lipid droplet staining, quantification of intracellular triglycerides, and secreted adiponectin levels, as well as expression analysis of multiple bona fide adipose markers. Lastly, we show that primary human hepatocytes maintain important functio
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.